Information Technology Award announced for pharmacy in 2010
- Details
- Category: Research
First DataBank Europe (FDBE) is pleased to announce, in association with The Guild of Healthcare Pharmacists (GHP) and the UK Clinical Pharmacy Association (UKCPA), the 2010 FDBE/GHP/UKCPA Information Technology Award.
Regular aspirin use may do more harm than good, study warns
- Details
- Category: Research
Can an aspirin a day keep the doctor away? New research, part of the EU-funded BIOMED (Biomedicine and health) programme, shows it can't all the time. The researchers have discovered that although regular use of aspirin can reduce the rate of non-fatal heart attacks or stroke by around 12%, there is a 33% increase in the risk of internal bleeding in people with no history of relevant disease (primary prevention). The findings are published in The Lancet journal.
From Pioneer to the World's Leading Scientific Network
- Details
- Category: Research
"Pioneers" was the headline when Science magazine covered the launch of the academic networking platform ResearchGATE exactly one year ago. In a very short time, a small group of pioneers in scientific communication, located at Harvard University and Hannover Medical School (Germany), has managed to create a worldwide community with more than 50,000 members from 196 countries.
Study sheds light on H1N1 origins
- Details
- Category: Research
The new H1N1 virus is only distantly related to its nearest relatives, suggesting that its genes may have been circulating undetected in pig populations for some time, according to new research published online by the journal Science.
Recognition for inventors in the fight against disease
- Details
- Category: Research
The fight against leukaemia and malaria - two of the world's most virulent diseases - was rewarded in two out of the four categories at the recent European Inventor of the Year awards. Swiss medicinal chemist Dr Jürg Zimmermann along with US oncologist Dr Brian Druker won the award in the Industry category for his invention of the drug Glivec. Glivec has a 98% remission rate in people suffering from chronic myelogenous leukaemia (CML) - a rare form of leukaemia that affects about 10,000 people every year.
New technology could lead to safer gene therapy
- Details
- Category: Research
EU-funded scientists have developed a new, non-viral way of getting genes into a cell. The technique appears to avoid the side-effects, such as cancer, which can occur when viruses are used to smuggle genes into a cell. The scientists hope their discovery will 'simplify the way gene therapy is conducted, improve its overall safety and reduce the costs'.
New online platform to help pharmaceutical companies find, evaluate and manage drug partners
- Details
- Category: Research
goBalto, an online drug development partnering site for the pharmaceutical development and drug manufacturing industry, announced today its new platform and website, goBalto.com. goBalto transforms the way drug-development partners are matched. The web-based platform enables members to quickly and efficiently find partners, share knowledge, and discover opportunities.
More Pharma News ...
- Physicians "Get Smart" - Number of Docs Using Smartphones Surges to 64% in 2009
- Tobacco gets new, healthy image
- Manhattan Research Releases Digital DTC Relevance Rankings
- Robots and scientists thinking together
- CAST PHARMA Announces a New Office in Denmark
- GoOn Research and Development Project Wins Theseus-Mittelstand
- Cancer Patients Connect with Online Communities for Care and Support